Pear Therapeutics Inc (PEARQ)

OTC Markets
0.004
-0.001(-11.36%)
  • Volume:
    494,874
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    0.004 - 0.005

PEARQ Overview

Prev. Close
0.004
Day's Range
0.004-0.005
Revenue
12.69M
Open
0.004
52 wk Range
0.003-4.48
EPS
-0.544
Volume
494,874
Market Cap
556.68K
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
9,834,574
P/E Ratio
-0.01
Beta
0.52
1-Year Change
-99.9%
Shares Outstanding
142,739,169
Next Earnings Date
Aug 11, 2023
What is your sentiment on Pear Therapeutics?
or
Market is currently closed. Voting is open during market hours.

Pear Therapeutics Inc Company Profile

Pear Therapeutics Inc Company Profile

Pear Therapeutics, Inc. is a commercial-stage healthcare company. The Company is engaged in developing a new class of software-based medicines that is referred to as prescription digital therapeutics (PDTs), which use software to treat diseases. Its products include reset, reSET-O and Somryst. The Company's reset product is indicated for the treatment of substance use disorder (SUD) related to alcohol, cannabis, cocaine and stimulants, such as monotherapy. Its reSET-O product is developed for the treatment of opioid use disorder (OUD) in combination with buprenorphine. The Company's Somryst product is the only software-based and guideline-recommended treatment for chronic insomnia. The Company’s pipeline consists of 14 product candidates, including candidates in psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal (GI), oncology, and cardiovascular. The Company focuses on psychiatric and neurologic conditions.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellStrong Sell
Technical IndicatorsNeutralNeutralBuySellStrong Sell
SummaryBuyBuyBuySellStrong Sell